Done sou Salè H1B

Akèy › Anplwayè › Vertex Pharmaceuticals Incorporated › Gene Editing Senior Research Scientist

Gene Editing Senior Research Scientist nan Vertex Pharmaceuticals Incorporated: Salè H-1B

5 aplikasyon kondisyon travay pou tit travay Gene Editing Senior Research Scientist nan Vertex Pharmaceuticals Incorporated. Salè baz medyàn ofri $124,842; mwatye mitan $124,842–$125,342.

Demann (LCA)5
Salè medyan ofri$124,842
Mwatye salè yo$124,842–$125,342
10yèm–90yèm pousantaj$122,867–$127,425

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20241$125,342
FY20253$124,842
FY20261$128,814

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$128,814–$189,500
Nivo III
Boston, MAFeb 26, 2026Feb 27, 2026Certifye
$124,842–$163,605
Nivo IV
Boston, MAFeb 25, 2025Aug 19, 2025Certifye
$124,842–$163,416
Nivo IV
Boston, MAFeb 24, 2025Aug 18, 2025Certifye
$121,550–$164,450
Nivo II
Boston, MANov 7, 2024Jan 6, 2025Certifye
$125,342–$169,581
Nivo II
Boston, MAMar 14, 2024Aug 3, 2024Certifye

Lòt travay nan Vertex Pharmaceuticals Incorporated

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).